KIORA PHARMACEUTICALS, INC. Operating Lease, Payments
KIORA PHARMACEUTICALS, INC. (KPRX) reported Operating Lease, Payments of $123.25 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2022-11-09
- KIORA PHARMACEUTICALS, INC. operating lease, payments for the quarter ending 2022-09-30 was $35.22K, a 65.48% increase year-over-year.
- KIORA PHARMACEUTICALS, INC. operating lease, payments for the quarter ending 2022-06-30 was $32.25K, a 5.22% increase year-over-year.
- KIORA PHARMACEUTICALS, INC. operating lease, payments for the quarter ending 2022-03-31 was $55.78K, a 0.07% increase year-over-year.
- KIORA PHARMACEUTICALS, INC. operating lease, payments for the quarter ending 2021-09-30 was $21.29K.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month |
|---|---|---|---|
| 2022-09-30 | $35.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $67.47K derived: sum of 2 quarters · filed 2022-11-09 | $123.25K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $32.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $88.03K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $55.78K 10-Q · filed 2022-07-08 | ||
| 2021-09-30 | $21.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $51.93K derived: sum of 2 quarters · filed 2022-11-09 | $107.67K 10-Q · filed 2022-11-09 |
| 2021-06-30 | $30.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $86.39K 10-Q · filed 2022-08-12 | |
| 2021-03-31 | $55.74K 10-Q · filed 2022-07-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |